Physician and nurse practitioner perspectives of a modified Routine Opioid Outcome Monitoring (ROOM) Tool
Cynthia Lam 1 2 , Patricia Marr 1 3 , Kori Leblanc
1 2 * , Christine Papoushek 1 3 , Debbie Kwan 1 2 , Beth Sproule 4 , Laura Murphy 1 2
1 University Health Network, Department of Pharmacy, Toronto, ON, Canada.
2 University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, ON, Canada.
3 University of Toronto, Department of Family and Community Medicine, Toronto, ON, Canada.
4 Centre for Addiction and Mental Health, Toronto, ON, Canada.
Journal of Primary Health Care 15(3) 246-252 https://doi.org/10.1071/HC23022
Published: 13 July 2023
Abstract
The Routine Opioid Outcome Monitoring (ROOM) Tool was developed for use in community pharmacies in Australia. It facilitates pharmacists’ screening and brief interventions regarding an individual’s opioid use for chronic pain. At our academic teaching hospital, the ROOM Tool was adapted to incorporate a communication tool that includes a pharmacist’s assessment and recommendations for primary care providers. This modified ROOM Tool was implemented as part of usual care in our outpatient pharmacies; however, the value to primary care providers is unknown.
The aim of this study was to determine primary care provider perspectives on the modified ROOM Tool.
Focus groups were conducted with primary care providers from an Academic Family Health Team. The focus group encompassed topics related to the positive and negative aspects of the modified ROOM Tool in supporting the care of patients using opioids for chronic pain. Qualitative content analysis of transcripts was performed to identify themes.
Three focus groups were conducted with a total of six participants. Four themes emerged: (i) Facilitators to using the tool, (ii) Barriers to using the tool, (iii) Recommendations for improvement, (iv) Impact of the tool on patient care and safety.
The ROOM Tool paired with the communication tool supports collaboration between pharmacists and primary care providers. The communication tool standardises the approach for communicating the pharmacist’s assessment and recommendations. Recommendations to refine this modified ROOM Tool may increase its utility to primary care providers and enhance the impact on patient care and safety.
Keywords: chronic pain, community pharmacy, facilitators and barriers, medication review, opioid use disorder, opioids, pharmacy practice, primary care.
References
1 Canadian Centre on Substance Use and Addiction. Prescription Opioids. Canada: Canadian Centre on Substance Use and Addiction; 2020. Available at https://www.ccsa.ca/prescription-opioids-canadian-drug-summary [updated 2020; cited 28 November 2021].
2 Harle CA, Bauer SE, Hoang HQ, et al. Decision support for chronic pain care: how do primary care physicians decide when to prescribe opioids? a qualitative study. BMC Fam Pract 2015; 16: 48.
| Crossref | Google Scholar |
3 Giannitrapani KF, Glassman PA, Vang D, et al. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management. BMC Fam Pract 2018; 19: 107.
| Crossref | Google Scholar |
4 Tsuyuki RT, Beahm NP, Okada H, et al. Pharmacists as accessible primary health care providers: review of the evidence. Can Pharm J 2018; 151(1): 4-5.
| Crossref | Google Scholar |
5 Iqbal A, David Knaggs R, Anderson C, et al. Role of pharmacists in optimising opioid therapy for chronic non-malignant pain; A systematic review. Res Social Adm Pharm 2020; 18: 2352-2366.
| Crossref | Google Scholar |
6 Nielsen S, Kowalski M, Wood P, et al. Routine opioid outcome monitoring in community pharmacy: pilot implementation study protocol. Res Social Adm Pharm 2019; 15(8): 1047-1055.
| Crossref | Google Scholar |
7 Picco L, Middleton M, Bruno R, et al. Validity and reliability of the computer-administered Routine Opioid Outcome Monitoring (ROOM) tool. Pain Med 2020; 21(12): 3645-3654.
| Crossref | Google Scholar |
8 Quality improvement primers. ON, Canada: Queen’s Printer for Ontario; 2013. Available at http://www.hqontario.ca/portals/0/documents/qi/qi‐science‐primer‐en.pdf
9 Jordan M, Latif A, Mullan J, et al. Opioid medicines management in primary care settings: a scoping review of quantitative studies of pharmacist activities. Br J Clin Pharmacol 2021; 87(12): 4504-4533.
| Crossref | Google Scholar |
10 Strand MA, Eukel H, Burck S. Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk. Res Social Adm Pharm 2019; 15(8): 1032-1036.
| Crossref | Google Scholar |
12 Clarke H, Soneji N, Ko DT, et al. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ 2014; 348: g1251.
| Crossref | Google Scholar |
13 Burcher KM, Suprun A, Smith A. Risk factors for opioid use disorders in adult postsurgical patients. Cureus 2018; 10(5): e2611.
| Crossref | Google Scholar |
14 Dubé P-A, Vachon J, Sirois C, et al. Opioid prescribing and dispensing: experiences and perspectives from a survey of community pharmacists practising in the province of Quebec. Can Pharm J 2018; 151(6): 408-418.
| Crossref | Google Scholar |
